
Tom R. Pettus
VerifiedUniversity of California, Santa Barbara · Chemistry and Biochemistry
Active 1989–2025
About
Tom R. Pettus is a professor in the Department of Chemistry & Biochemistry at the University of California, Santa Barbara. His specialization includes Organic & Bioorganic Molecular Design & Synthesis, Biomedical Sciences, and Biology-Inspired Chemistry & Physics. Dr. Pettus obtained his Ph.D. in 1996 from the University of Rochester, working with Professor R. H. Schlessinger, after completing his undergraduate research with Professor Tomás Hudlicky at VPI. He conducted postdoctoral research as an NSF Postdoctoral Fellow at Columbia University with Professor S. J. Danishefsky before joining UCSB in 1998. His research group focuses on developing new methods and strategies for constructing architecturally complex tetramic acid derivatives, which are significant due to their presence in natural products with diverse biological activities, including antimicrobial, antiviral, and antifungal properties. His work aims to improve the efficiency of synthesizing these compounds, especially in enantioselective manners, with ongoing projects involving the total synthesis of natural products like tetrapetalone A. Dr. Pettus has been recognized with awards such as the Research Innovation Award from Research Corporation and an NSF-Career Grant. His research contributes to the understanding and development of synthetic methods for complex heterocyclic architectures, with implications for pharmaceutical and biological applications.
Research topics
- Chemistry
- Combinatorial chemistry
- Stereochemistry
- Organic chemistry
- Materials science
Selected publications
Allosteric Inhibitors of Cell-Cycle-Regulated Methyltransferase for Novel Antibiotic Development
ACS Omega · 2025-04-09
articleOpen accessCorrespondingCell-cycle-regulated methyltransferase (CcrM) plays a crucial role in regulating important cellular processes that are essential for proper cell division and growth; disruptions of these processes can attenuate the bacteria's viability. Notably, CcrM homologs are present across a set of diverse human pathogens, suggesting that selective inhibition of CcrM over human DNA methyltransferases (DNMT's) could offer a new strategy for combating human bacterial pathogens, leading to the development of novel antibiotics. Herein, we report the screening of two open-access chemical libraries-the National Cancer Institute Developmental Therapeutic Program Diversity Set VII and Medicines for Malaria Venture Global Health Priority Box-and identified four structurally diverse inhibitors of CcrM. Among these, two inhibitors displayed both micromolar affinity and high selectivity for CcrM over human DNA methyltransferase 3A, highlighting their potential as leads for a new class of antibiotics.
ACS Medicinal Chemistry Letters · 2024-04-08 · 3 citations
articleOpen accessCorrespondingThe development of new therapeutics targeting enzymes involved in epigenetic pathways such as histone modification and DNA methylation has received a lot of attention, particularly for targeting diverse cancers. Unfortunately, irreversible nucleoside inhibitors (azacytidine and decitabine) have proven highly cytotoxic, and competitive inhibitors are also problematic. This work describes synthetic and structural investigations of a new class of allosteric DNA methyltransferase 3A (DNMT3A) inhibitors, leading to the identification of several critical pharmacophores in the lead structure. Specifically, we find that the tetrazole and phthalazinone moieties are indispensable for the inhibitory activity of DNMT3A and elucidate other modifiable regions in the lead compound.
Synthesis · 2023-06-28 · 1 citations
articleOpen access1st authorCorrespondingAbstract Herein, we report the first total synthesis of (±)-marilines B and C, as well as a failed approach to (±)-mariline A, by using our recently developed multicomponent reaction method, which involves the interception of ortho-quinone methides with various nitrogen nucleophiles to allow easy assembly of various benzylic amine cores with diverse substituents.
The Journal of Organic Chemistry · 2023-01-31 · 2 citations
articleOpen accessSenior authorCorrespondingA novel method for joining four components together in a single pot leading to an assortment of N-amino-benzylated phenols is described. The method involves the addition of different Grignard reagents to various o-OBoc salicylaldehydes in the presence of assorted 4,5-dihydrooxazoles, followed by aqueous workup. Seventeen examples are presented with varied (-R, -R′ -R″, -R‴, -R⁗, and Cn) substituents.
Strategies for ortho-tert-Butylation of Phenols and their Analogues
Synlett · 2022-01-28
articleOpen access1st authorCorrespondingAbstract A new general process for constructing ortho-tert-butyl phenols is presented within the context of other known methods. All are briefly evaluated with regards to regioselectivity, efficiency, and functional group tolerance. In addition, we present an assortment of tert-butyl substrates accessed through o-QM chemistry. Our conclusion is that the o-QM process provides greater yields, flexibility, and generality than most other known methods for delivering ortho-tert-buytlated phenols and their derivatives. 1 Introduction 2 Friedel–Crafts Alkylation 3 Addition of t-Bu– or t-Bu• to Carbonyl Compounds 4 ipso-SNAr Reactions of Aryl Methoxy and tert-Butylsulfoxide Moieties 5 Metal-Mediated Coupling of Aryl Bromides 6 Applications of o-Quinone Methides (o-QMs) 7 Conclusion
Tetrapetalones ruminations, trials and tribulations
Strategies and tactics in organic synthesis · 2021-01-01
book-chapterSenior authorCorrespondingOrganic Letters · 2019-09-18 · 8 citations
articleSenior authorCorrespondingA one-pot method for joining three separate components leading to an assortment of N-substituted 3,4-dihydro-2H-1,3-benzoxazines is described. The method involves the addition of a Grignard reagent to an o-OBoc salicylaldehyde in the presence of an imine. With a variety of components, 15 examples are presented, including the diastereoselective incorporation of chiral imines.
A Biomimetic Synthesis of des-Hydroxy Paecilospirone
Synlett · 2018-05-09 · 7 citations
articleOpen access1st authorCorrespondingThe carbon framework of des-hydroxy paecilospirone was rapidly synthesized using a biomimetic approach whereby an enol ether and an ortho-quinone methide (o-QM), each derived from the same lactone, were combined to arrive at the complete carbon skeleton of paecilospirone.
Organic Letters · 2018-01-30 · 14 citations
articleSenior authorA strategy toward tetrapetalones was explored including a site-selective ethylenation of the silyl enol ether A to afford a quaternary stereocenter that serves in a stereogenic capacity. Regio- and diastereoselective reactions were observed in conjunction with the oxidative formation of cation B, which included subsequent selective formation of either carbon-oxygen or carbon-carbon bonds at the δ or ζ position on the seven-membered ring. The fourth ring was formed using a Stetter reaction.
ChemInform · 2015-02-19
articleSenior authorAbstract The title process proceeds with good to excellent syn selectivity to provide the corresponding aldol products.
Recent grants
NIH · $2.4M · 2015
CAREER: New Applications for Ortho-Quinone Methides in Organic Synthesis
NSF · $463k · 2002–2007
Organic Synthesis with Quinone Methides and their Adducts
NSF · $396k · 2008–2012
Frequent coauthors
- 28 shared
C. Selenski
- 20 shared
Xiaotao Chen
University of Science and Technology of China
- 19 shared
Samuel J. Danishefsky
Kettering University
- 17 shared
Wen‐Ju Bai
AbbVie (United States)
- 13 shared
Clare E. Gutteridge
United States Naval Academy
- 12 shared
Samit K. Bhattacharya
Pfizer (United States)
- 12 shared
Ryan W. Van De Water
University of California, Santa Barbara
- 11 shared
Yaodong Huang
Shenzhen University
Labs
Pettus GroupPI
Education
- 1996
Ph.D., Chemistry
University of Rochester
Awards & honors
- Research Innovation Award from Research Corporation
- NSF CAREER Grant
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Tom R. Pettus
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup